The University of Chicago Header Logo

Connection

Yonglin Pu to Antigens, CD19

Back to Details
This is a "connection" page, showing publications Yonglin Pu has written about Antigens, CD19.
Yonglin Pu
Connection Strength
0.048
Antigens, CD19
  1. Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 06 17; 137(24):3454-3459.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.